Seroprevalence and Genotypic Distribution Patterns of Hepatitis C Virus among Infected Patients from Sulaimaniyah Province: Iraq


  • Awat Jamal Hasan Department of Community Health Nursing, College of Nursing, University of Sulaimani, Kurdistan Region, Iraq. Author
  • Zhian Salah Ramzi Department of Community Medicine, College of Medicine, University of Sulaimani, Kurdistan Region, Iraq. Author
  • Mohammed Abdulrahman Alshekhani Department of Community Medicine, College of Medicine, University of Sulaimani, Kurdistan Region, Iraq. Author



HCV Genotyping, Seroprevalence, Liver disease, Cross-sectional study


Background: The hepatitis C virus (HCV) is a prevalent cause of liver illness. The virus displays a high degree of genetic variability, with documented geographical differences in genotype predominance.


Objective: This study aimed to determine the prevalence of HCV genotypes among people who lived in Sulaimaniyah province, Kurdistan region of Iraq.


Patients and Methods: Blood samples were collected from 229 individuals identified as having a confirmed positive HCV antibody and who had been referred to the Public Health Laboratory in Sulaimaniyah city by medical professionals for genotyping from July 2021 to December 2022. Following the extraction of the viral RNA, a PCR-based genotyping kit was used to identify the HCV genotype.


Results: The most prevalent genotype was GT1a (31.6%), followed by GT1 and GT4 (23.6%) and then GT1b (7.9%). Mixed genotypes were observed in 10.4% of samples. Males were affected mainly by HCV (58.5%) than females (41.5%). The frequency of GT1a was higher in males (32.1%) compared to females (30.5%). On the other hand, males exhibited a more excellent distribution of GT4 and GT1 than females, while GT1b and GT5 were observed more in females than males. Among mixed genotypes, GT5 or 6 was the most prevalent infection type (no.=8, 3.5%), while GT1a, 3 reported the lowest rate (no.=1, 0.4%).


Conclusion: This study assesses the HCV genotype distribution among infected HCV patients in Sulaimaniyah, which is distinct from the prevalent distribution in Iraq and Middle Eastern Arab nations, but it is equivalent to the distribution worldwide.


Stasi C., Silvestri C. & Voller F. (2020). Update on Hepatitis C Epidemiology: Unaware and Untreated Infected Population Could Be the Key to Elimination. SN Comprehensive Clinical Medicine. 2(12), 2808–2815. DOI:

Khudhair H.A., Albakaa A.H. & Hussein K.R. (2020). Detection the Prevalence of Hepatitis C Virus among Iraqi People. bioRxiv. DOI:

Kareem B.O. & Salih G.F. (2014). Hepatitis C Virus Genotyping in Sulaimani Governorate. European Scientific Journal. 10(15), 1857–7881.

Namayandeh M., Jamalidoust M., Heydari M.N., Aliabadi N., Ziyaeyan A., Pouladfar G. & Ziyaeyan M. (2020). Hepatitis C virus genotypes in patients with chronic hepatitis C infection in southern Iran from 2016 to 2019. Microbiology & Immunology. 64(11), 762–767. DOI:

Al Kanaani Z., Mahmud S., Kouyoumjian S.P. & Abu-Raddad L.J. (2018). The epidemiology of hepatitis C virus in Pakistan: Systematic review and meta-analyses. Royal Society Open Science. 5(4), 180257. DOI:

Di Maio V.C., Barbaliscia S., Teti E., Fiorentino G., Milana M., Paolucci S., Pollicino T., Morsica G., Starace M., Bruzzone B. & Gennari W. (2021). Resistance analysis and treatment outcomes in hepatitis C virus genotype 3-infected patients within the Italian network VIRONET-C. Liver International. 41(8), 1802–1814. DOI:

Ullah N., Kakakhel M.A., Bai Y., Xi L., Khan I., Kalra B.S., Kumar T., Ahmad H., Shah M., Guanlan L. & Zhang C. (2021). Prevalence of active HCV infection and genotypic distribution among the general population of district Mardan, Pakistan. Brazelian Journal of Biology. 83, e244977. DOI:

Gagné M., Têtu I., Grégoire J.P. & Moisan J. (2021). Adherence and sustained virologic response among vulnerable people initiating an hepatitis C treatment at a nurse-led clinic: A non-experimental prospective cohort study based on clinical records. International Journal of Nursing Studies Advances. 3, 100029. DOI:

Dopico E., Rodriguez-Frias F., Ubillos I., Rando-Segura A., Garcia-Cehic D., Gregori J., Rando-Matos Y., Solsona L., Niubó J., Esteban J.I. & Costa J. (2022). Prevalence of Hepatitis C Virus Infection, Genotypes and Subtypes in Migrants from Pakistan in Barcelona, Spain. Infection & Drug Resistance. 15, 4637–4644. DOI:

Yang J., Liu H.X., Su Y.Y., Liang Z.S. & Rao H.Y. (2022). Distribution and changes in hepatitis C virus genotype in China from 2010 to 2020. World Journal of Clinical Cases. 10(14), 4480–4493. DOI:

Hedskog C., Parhy B., Chang S., Zeuzem S., Moreno C., Shafran S.D., Borgia S.M., Asselah T., Alric L., Abergel A. & Chen J.J. (2019). Identification of 19 novel hepatitis C virus subtypes-further expanding HCV classification. Open Forum Infectious Diseases. 6(3), ofz076. DOI:

Hassan D.A., Maulud S.Q., Saeed R.H. & Nore B.F. (2018). Seroprevalence and Genotypic Distribution Patterns of Hepatitis C Virus among Infected Patients from Erbil Province: Kurdistan/Iraq. Diyala Journal of Medicine. 14(1), 84–93. DOI:

Alshaikhly A.W., Musa Z.A., Qasim B.J., Ghazi H.F. & Mohammed W.J. (2020). The distribution of hepatitis c virus genotypes, viral load and antibody titer among iraqi chronic hepatitis patients. Medico-Legal Update. 20(1), 1136–1142.

Maklef Al-Hmudi N.A. (2016). Genotyping of Hepatitis C Virus (HCV) in Patients of Basra Province/Iraq. International Journal of Innovative Research in Science, Engineering and Technology. 5(6), 10363–10368. DOI:

Farag M.M., Sofy A.R., Mousa A.A., Ahmed M.A., & Alganzory M.R. (2015). Molecular assay and genotyping of hepatitis C virus among infected egyptian and saudi arabian patients. Virology Research and Treatment. 6, 1–10. DOI:

Ghaderi-Zefrehi H., Gholami-Fesharaki M., Sharafi H., Sadeghi F., & Alavian S.M. (2016). The distribution of hepatitis C virus genotypes in middle eastern countries: A systematic review and meta-analysis. Hepatitis Monthly. 16(9), e40357. DOI:

Hussein N.R., Balatay A.A., Sezgin A.T., & Jawad R.S. (2017). The distribution of HCV in subjects attending hospitals in Duhok City, Iraq. Asian Pacific Journal of Tropical Biomedicine. 7(3), 262–264. DOI:

Khan N., Akmal M., Hayat M., Umar M., Ullah A., Ahmed I., Rahim K., Ali S., Bahadar S., & Saleha S. (2014). Geographic distribution of hepatitis C virus genotypes in pakistan. Hepatis Monthly. 14(10), 14–18. DOI:

Abdel-Ghaffar T.Y., Sira M.M., & El Naghi S. (2015). Hepatitis C genotype 4: The past, present, and future. World Journal of Hepatology. 7(28), 2792–2810. DOI:



How to Cite

Seroprevalence and Genotypic Distribution Patterns of Hepatitis C Virus among Infected Patients from Sulaimaniyah Province: Iraq. (2023). Journal of Zankoy Sulaimani - Part A, 25(1), 9.